OSCR
Oscar Health, Inc.
NYSE · Healthcare · Medical - Healthcare Plans · US
$32.54
+2.04%Year over year
Reported trailing growth
- Revenue
- +42.8%
- EBITDA
- +751.9%
- EBIT
- +567.8%
- EPS
- +371.4%
- Free cash flow
- +260.8%
- Operating cash flow
- +254.3%
Forward estimates
Based on analyst estimates
- Revenue
- +32.8%
- EBITDA
- +78.8%
- EPS
- +35.6%
Three-year CAGR
- Revenue
- +41.6%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +44.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026